Dr. Tyler Wenzel, a former high school science teacher and now a stem cell researcher, believes the recent recognition will help highlight Saskatchewan’s growing role in healthcare and biomedical innovation.

According to Dr. Wenzel, Saskatchewan is increasingly becoming home to advanced hospitals, skilled physicians, and innovative research that could benefit patients across the province.

Their current research focuses on X-linked Adrenoleukodystrophy (X-ALD), a rare and potentially life-threatening genetic disorder that can cause severe deterioration of the brain. Patients in Saskatchewan who develop the disease currently need to travel to Manitoba or Alberta for treatment because the province does not yet have the facilities or capacity to perform the required transplants.

Dr. Wenzel is investigating a stem cell transplant approach that could potentially treat the disease while reducing the need for intensive chemotherapy and radiation, which are commonly associated with conventional bone marrow transplantation.

Preliminary findings from the Stem Cell Network indicate that the approach may cause disease markers to disappear. Researchers are now investigating whether this could also prevent or reverse the symptoms associated with the disease.

If successful, the approach could eventually provide an alternative treatment pathway for more than a dozen pediatric neurological diseases that currently require chemotherapy or radiation followed by bone marrow transplantation.

Dr. Wenzel estimates that, if research and regulatory preparations progress as planned, patients in Saskatchewan could potentially begin receiving this treatment locally within the next decade. Significant quality-control, clinical, and regulatory requirements still need to be addressed before the therapy can be used in humans.

The research team is also seeking individuals affected by X-ALD and people who have previously undergone stem cell transplants to share their experiences and, where appropriate, participate in research. Patient-derived skin samples are being used to evaluate whether the proposed therapy can effectively address disease-related markers before progressing toward human applications.

The research represents part of a broader effort to expand Saskatchewan’s biomedical and regenerative medicine capabilities. As research infrastructure and expertise continue to grow at the University of Saskatchewan, Dr. Wenzel and other researchers hope to develop new regenerative therapies for a range of serious diseases.

Dr. Wenzel’s commitment to pediatric health is deeply personal, shaped by experiences as a former teacher and witnessing children become seriously ill. Their work reflects a long-standing goal of developing safer and more accessible treatments for children facing life-threatening diseases.

Source: https://globalnews.ca/news/12089659/usask-professor-recognized-for-pediatric-stem-cell-research/